Reshma Kewalramani Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Reshma Kewalramani has an estimated net worth of at least $89.1 million*, as of Dec. 18, 2024. They own 75,772 shares of VRTX stock. They have sold 134,222 shares of VRTX stock since 2021, for an estimated $53.6 million.
Reshma Kewalramani $VRTX SEC Form 4 Insider Trading
Reshma Kewalramani has filed a total of 17 insider trades in $VRTX since 2021. Their most recent trade was a sale of 15,198 shares, made on Nov 08, 2024. Their largest trade was a sale of 17,135 shares, made on Dec 15, 2023. We estimate that they now own 75,772 shares of $VRTX, worth an estimated $35.5 million.
Insider Trading at $VRTX
There have been a total of 474 insider trades reported at $VRTX since 2021, with 25,000 shares purchased and 808,928 shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Bastiano Sanna, and Ourania Tatsis. The most recent trade was a sale of 15 shares reported by DAVID ALTSHULER (EVP, Chief Scientific Officer), made on Nov 15, 2024.
History of Insider Stock Trades by Reshma Kewalramani
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Sale | 15,198 | Nov 08, 2024 | Nov. 12, 2024, 5:08 p.m. |
|
VRTX
|
Sale | 15,202 | Jul 30, 2024 | Aug. 1, 2024, 4:17 p.m. |
|
VRTX
|
Sale | 15,202 | Jul 22, 2024 | July 24, 2024, 4:05 p.m. |
|
VRTX
|
Sale | 1,565 | May 24, 2024 | May 29, 2024, 4:08 p.m. |
|
VRTX
|
Sale | 15,202 | May 20, 2024 | May 22, 2024, 4:21 p.m. |
|
VRTX
|
Sale | 17,135 | Dec 15, 2023 | Dec. 19, 2023, 5:15 p.m. |
|
VRTX
|
Sale | 5,098 | Dec 13, 2023 | Dec. 15, 2023, 5:23 p.m. |
|
VRTX
|
Sale | 5,097 | Nov 13, 2023 | Nov. 15, 2023, 5:16 p.m. |
|
VRTX
|
Sale | 7,828 | Jul 17, 2023 | July 18, 2023, 4:13 p.m. |
|
VRTX
|
Sale | 1,611 | Apr 27, 2023 | May 1, 2023, 4:26 p.m. |
|
VRTX
|
Sale | 38 | Apr 27, 2023 | May 1, 2023, 4:26 p.m. |
|
VRTX
|
Sale | 1,668 | Apr 27, 2023 | May 1, 2023, 4:26 p.m. |
|
VRTX
|
Sale | 10,000 | Jan 25, 2023 | Jan. 27, 2023, 5:13 p.m. |
|
VRTX
|
Sale | 11,689 | Aug 15, 2022 | Aug. 17, 2022, 5:40 p.m. |
|
VRTX
|
Sale | 11,689 | Jun 24, 2022 | June 28, 2022, 4:05 p.m. |
|
VRTX
|
Purchase | 5,757 | Aug 19, 2021 | Aug. 22, 2021, 8 p.m. |
|
VRTX
|
Purchase | 4,243 | Aug 19, 2021 | Aug. 22, 2021, 8 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Stuart A Arbuckle, EVP, COO
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Jeffrey M Leiden, Executive Chairman
-
Joy Liu, SVP, General Counsel
-
Reshma Kewalramani, CEO & President
-
Carmen Bozic, EVP and CMO
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Amit Sachdev, EVP, Chief Patient Officer
-
Jonathan Biller, EVP and Chief Legal Officer
-
David Altshuler, EVP, Chief Scientific Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.